미국의 인간배아줄기세포 연구의 규제 동향

As the stem cell enables the treatment of fundamental cause of disease and the customized treatment for individual, so is expected to become a driving force of future medical industry. As a stem cell-utilizing medicine can replace a damaged organ with a new one or restore it into a normal organ, so is expected to delete the fundamental cause of disease. Moreover, as the stem cell can be extracted from an individual’s body and can make appropriate medicines and organs for the individual, so each patient-customized treatment will be possible. Though most medicines vary the degrees of its therapeutic effects and side effects depending on different characteristics by race and by individual, but the stem cell-utilizing medicine has the advantages to complement such disadvantages. So the stem cell is also called as the ‘gold mine of medical industry.’U.S administration’s initial policy on the researches dealing with the human embryonic stem cell was the conditional approval only to the private field’s research support. After then, Obama administration enabled to support the U.S. federal fund to the researches on the human embryonic stem cell, and as the results from the U.S’ such active support, international competition for preoccupying the superior position in the researches human embryonic stem cell became fierce based on each nation’s tremendous researchsupporting fund. Contrary to Korean position supporting the stem cell research, the U.S.A is the nation where the intensive confrontation between the competitiveness in the stem cell research and the bioethics has long been kept. In the U.S. administration and the Congress during the period from Clinton administration to Obama administration, there have continually been raised ethical, political controversies due to the both values. This thesis investigated the U.S’ regulation trend on the researches about human embryonic stem cell by the institution, the presidential term, and each state.